SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-25
👔
Kymera Therapeutics, Inc.
@KYMR_InsiderForm 4 Filing: Goodman Noah Sells $675,250 of $KYMR
INSIDER SALE
⚡ MATERIALITY: 6/10
corporate issuer
Kymera Therapeutics, Inc.
Ticker: $KYMR
Transaction Value
$675,250
Price/Share: $67.53
transaction date
2026-06-25
Shares: 10,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Goodman Noah, holds the title of Chief Business Officer at Kymera Therapeutics, Inc..
On 2026-06-25, the insider transacted 10,000 shares.The shares were transacted at a weighted average price of $67.53 per share, resulting in a total market-relevant value of $675,250.
Executive Summary Summary
Goodman Noah (Chief Business Officer) sold $675K of $KYMR
Post-Transaction Position: 50,195.438 shares
SEC Accession No: 0001193125-26-283139 (CIK: 2060075)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.